Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for ADT-Induced Metabolic Syndrome in Prostate Cancer
NCT01077479Phase 2Completed
- Sponsor
- Western Sydney Local Health District
- Start
- Feb 2010
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in insulin resistance (IR), metabolic syndrome, hypercholesterolemia, sponsored by Western Sydney Local Health District. Started Feb 2010; status: completed.
02
Drugs
metformin
03
Conditions
insulin resistance (IR)metabolic syndromehypercholesterolemia
Beyond the preview
Go deeper on NCT01077479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01077479.